Sign up for free insights newsletter
PH

Koninklijke Philips NV

PHI1XETRA (Frankfurt)

Need professional-grade analysis? Visit stockanalysis.com

€23.08
+1.14%
End of day
Market Cap

$23.22B

P/E Ratio

26.25

Employees

61,085

Dividend Yield

3.44%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-1.50-2.59-0.07-0.130.09-0.38-0.44
Calmar-16.86-5.01-0.09-0.160.10-0.13-1.40
Sharpe-1.24-2.46-0.04-0.090.06-0.27-0.38
Omega0.210.391.031.011.040.980.91
Martin-22.83-10.08-0.24-0.460.24-0.20-2.27
Ulcer3.927.896.406.087.3248.2217.05

Koninklijke Philips NV (PHI1) Price Performance

Koninklijke Philips NV (PHI1) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at EUR23.08, up 1.14% from the previous close.

Over the past year, PHI1 has traded between a low of EUR18.83 and a high of EUR27.57. The stock has gained 2.3% over this period. It is currently 16.3% below its 52-week high.

Koninklijke Philips NV has a market capitalization of $23.22B, with a price-to-earnings ratio of 26.25 and a dividend yield of 3.44%.

About Koninklijke Philips NV

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Company Info

Exchange
XETRA (Frankfurt)
Currency
EUR
Country
Germany

Financial Metrics

Revenue (TTM)
$17.83B
EBITDA
$2.02B
Profit Margin
5.02%
EPS (TTM)
0.93
Book Value
11.52

Technical Indicators

52 Week High
€27.57
52 Week Low
€18.60
50 Day MA
€25.40
200 Day MA
€23.56
Beta
0.94

Valuation

Trailing P/E
26.25
Forward P/E
15.41
Price/Sales
1.30
Price/Book
2.12
Enterprise Value
$28.24B